Found 110 hits with Last Name = 'tracy' and Initial = 'jl' Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50142480
((E)-7-[(1R,2S,3R)-3-Hydroxy-2-((E)-(S)-3-hydroxy-o...)Show SMILES CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)N1C\C=C\CCCC(O)=O Show InChI InChI=1S/C19H31NO5/c1-2-3-6-9-15(21)11-12-16-17(22)14-18(23)20(16)13-8-5-4-7-10-19(24)25/h5,8,11-12,15-17,21-22H,2-4,6-7,9-10,13-14H2,1H3,(H,24,25)/b8-5+,12-11+/t15-,16-,17+/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| 0.800 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP4 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50142482
(7-{(R)-2-[(E)-(S)-3-Hydroxy-4-(3-trifluoromethyl-p...)Show SMILES O[C@@H](Cc1cccc(c1)C(F)(F)F)\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O Show InChI InChI=1S/C22H28F3NO4/c23-22(24,25)17-7-5-6-16(14-17)15-19(27)11-9-18-10-12-20(28)26(18)13-4-2-1-3-8-21(29)30/h5-7,9,11,14,18-19,27H,1-4,8,10,12-13,15H2,(H,29,30)/b11-9+/t18-,19+/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 1.60 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Agonist activity against recombinant prostanoid EP4 receptor stably transfected in CHO cells |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50142476
(7-{(R)-2-[(E)-3-(4'-Chloro-2'-methyl-biphenyl-3-yl...)Show SMILES Cc1cc(Cl)ccc1-c1cccc(c1)C(O)\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O Show InChI InChI=1S/C27H32ClNO4/c1-19-17-22(28)10-13-24(19)20-7-6-8-21(18-20)25(30)14-11-23-12-15-26(31)29(23)16-5-3-2-4-9-27(32)33/h6-8,10-11,13-14,17-18,23,25,30H,2-5,9,12,15-16H2,1H3,(H,32,33)/b14-11+/t23-,25?/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid UniChem
Similars
| Article PubMed
| 3.10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP4 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50142474
(7-[(R)-2-((E)-(S)-4-Cyclobutyl-3-hydroxy-but-1-eny...)Show SMILES O[C@@H](CC1CCC1)\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O Show InChI InChI=1S/C19H31NO4/c21-17(14-15-6-5-7-15)11-9-16-10-12-18(22)20(16)13-4-2-1-3-8-19(23)24/h9,11,15-17,21H,1-8,10,12-14H2,(H,23,24)/b11-9+/t16-,17+/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 4.20 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP4 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP1 subtype
(Homo sapiens (Human)) | BDBM50142480
((E)-7-[(1R,2S,3R)-3-Hydroxy-2-((E)-(S)-3-hydroxy-o...)Show SMILES CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)N1C\C=C\CCCC(O)=O Show InChI InChI=1S/C19H31NO5/c1-2-3-6-9-15(21)11-12-16-17(22)14-18(23)20(16)13-8-5-4-7-10-19(24)25/h5,8,11-12,15-17,21-22H,2-4,6-7,9-10,13-14H2,1H3,(H,24,25)/b8-5+,12-11+/t15-,16-,17+/m0/s1 | KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| 4.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP1 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50142481
(7-[(R)-2-((E)-(S)-3-Hydroxy-oct-1-enyl)-5-oxo-pyrr...)Show SMILES CCCCC[C@H](O)\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O Show InChI InChI=1S/C19H33NO4/c1-2-3-6-9-17(21)13-11-16-12-14-18(22)20(16)15-8-5-4-7-10-19(23)24/h11,13,16-17,21H,2-10,12,14-15H2,1H3,(H,23,24)/b13-11+/t16-,17-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 4.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP4 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50142492
(7-{(R)-2-[(E)-3-Hydroxy-3-(4'-hydroxy-2'-methyl-bi...)Show SMILES Cc1cc(O)ccc1-c1cccc(c1)C(O)\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O Show InChI InChI=1S/C27H33NO5/c1-19-17-23(29)12-13-24(19)20-7-6-8-21(18-20)25(30)14-10-22-11-15-26(31)28(22)16-5-3-2-4-9-27(32)33/h6-8,10,12-14,17-18,22,25,29-30H,2-5,9,11,15-16H2,1H3,(H,32,33)/b14-10+/t22-,25?/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 4.90 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP4 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50125417
(7-[(R)-2-((E)-3-Hydroxy-4-phenyl-but-1-enyl)-5-oxo...)Show SMILES OC(Cc1ccccc1)\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O Show InChI InChI=1S/C21H29NO4/c23-19(16-17-8-4-3-5-9-17)13-11-18-12-14-20(24)22(18)15-7-2-1-6-10-21(25)26/h3-5,8-9,11,13,18-19,23H,1-2,6-7,10,12,14-16H2,(H,25,26)/b13-11+/t18-,19?/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 6.10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Agonist activity against recombinant prostanoid EP4 receptor stably transfected in CHO cells |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50142493
(7-{(R)-2-[(E)-3-(2'-Chloro-biphenyl-3-yl)-3-hydrox...)Show SMILES OC(\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O)c1cccc(c1)-c1ccccc1Cl Show InChI InChI=1S/C26H30ClNO4/c27-23-11-5-4-10-22(23)19-8-7-9-20(18-19)24(29)15-13-21-14-16-25(30)28(21)17-6-2-1-3-12-26(31)32/h4-5,7-11,13,15,18,21,24,29H,1-3,6,12,14,16-17H2,(H,31,32)/b15-13+/t21-,24?/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 6.20 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP4 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50142480
((E)-7-[(1R,2S,3R)-3-Hydroxy-2-((E)-(S)-3-hydroxy-o...)Show SMILES CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)N1C\C=C\CCCC(O)=O Show InChI InChI=1S/C19H31NO5/c1-2-3-6-9-15(21)11-12-16-17(22)14-18(23)20(16)13-8-5-4-7-10-19(24)25/h5,8,11-12,15-17,21-22H,2-4,6-7,9-10,13-14H2,1H3,(H,24,25)/b8-5+,12-11+/t15-,16-,17+/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| 6.40 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP2 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50142489
(7-{(S)-2-[(R)-3-Hydroxy-3-(3-trifluoromethyl-pheny...)Show SMILES O[C@H](CC[C@H]1CCC(=O)N1CCCCCCC(O)=O)c1cccc(c1)C(F)(F)F Show InChI InChI=1S/C21H28F3NO4/c22-21(23,24)16-7-5-6-15(14-16)18(26)11-9-17-10-12-19(27)25(17)13-4-2-1-3-8-20(28)29/h5-7,14,17-18,26H,1-4,8-13H2,(H,28,29)/t17-,18+/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 7.40 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP4 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50142477
(7-[(R)-2-((E)-(S)-4-Cyclohexyl-3-hydroxy-but-1-eny...)Show SMILES O[C@@H](CC1CCCCC1)\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O Show InChI InChI=1S/C21H35NO4/c23-19(16-17-8-4-3-5-9-17)13-11-18-12-14-20(24)22(18)15-7-2-1-6-10-21(25)26/h11,13,17-19,23H,1-10,12,14-16H2,(H,25,26)/b13-11+/t18-,19+/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 7.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP4 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP3 subtype
(Homo sapiens (Human)) | BDBM50142480
((E)-7-[(1R,2S,3R)-3-Hydroxy-2-((E)-(S)-3-hydroxy-o...)Show SMILES CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)N1C\C=C\CCCC(O)=O Show InChI InChI=1S/C19H31NO5/c1-2-3-6-9-15(21)11-12-16-17(22)14-18(23)20(16)13-8-5-4-7-10-19(24)25/h5,8,11-12,15-17,21-22H,2-4,6-7,9-10,13-14H2,1H3,(H,24,25)/b8-5+,12-11+/t15-,16-,17+/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| 8 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP3 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50142484
(7-{(S)-2-[(R)-3-Hydroxy-3-(4'-hydroxy-2'-methyl-bi...)Show SMILES Cc1cc(O)ccc1-c1cccc(c1)[C@H](O)CC[C@H]1CCC(=O)N1CCCCCCC(O)=O Show InChI InChI=1S/C27H35NO5/c1-19-17-23(29)12-13-24(19)20-7-6-8-21(18-20)25(30)14-10-22-11-15-26(31)28(22)16-5-3-2-4-9-27(32)33/h6-8,12-13,17-18,22,25,29-30H,2-5,9-11,14-16H2,1H3,(H,32,33)/t22-,25+/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 8.20 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP4 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50142490
(7-{(R)-2-[(E)-3-Hydroxy-3-(5-trifluoromethyl-furan...)Show SMILES OC(\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O)c1ccc(o1)C(F)(F)F Show InChI InChI=1S/C19H24F3NO5/c20-19(21,22)16-10-9-15(28-16)14(24)8-6-13-7-11-17(25)23(13)12-4-2-1-3-5-18(26)27/h6,8-10,13-14,24H,1-5,7,11-12H2,(H,26,27)/b8-6+/t13-,14?/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| 10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP4 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50125409
(7-{(R)-2-[(E)-3-Hydroxy-3-(1-phenyl-cyclopropyl)-p...)Show SMILES OC(\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O)C1(CC1)c1ccccc1 Show InChI InChI=1S/C23H31NO4/c25-20(23(15-16-23)18-8-4-3-5-9-18)13-11-19-12-14-21(26)24(19)17-7-2-1-6-10-22(27)28/h3-5,8-9,11,13,19-20,25H,1-2,6-7,10,12,14-17H2,(H,27,28)/b13-11+/t19-,20?/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 12 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP4 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50142488
(7-((S)-2-((R)-3-hydroxy-4-(3-(trifluoromethyl)phen...)Show SMILES O[C@H](CC[C@H]1CCC(=O)N1CCCCCCC(O)=O)Cc1cccc(c1)C(F)(F)F Show InChI InChI=1S/C22H30F3NO4/c23-22(24,25)17-7-5-6-16(14-17)15-19(27)11-9-18-10-12-20(28)26(18)13-4-2-1-3-8-21(29)30/h5-7,14,18-19,27H,1-4,8-13,15H2,(H,29,30)/t18-,19+/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 16 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP4 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50142486
(7-{(R)-2-[(E)-3-Hydroxy-3-(3-phenoxy-phenyl)-prope...)Show SMILES OC(\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O)c1cccc(Oc2ccccc2)c1 Show InChI InChI=1S/C26H31NO5/c28-24(20-9-8-12-23(19-20)32-22-10-4-3-5-11-22)16-14-21-15-17-25(29)27(21)18-7-2-1-6-13-26(30)31/h3-5,8-12,14,16,19,21,24,28H,1-2,6-7,13,15,17-18H2,(H,30,31)/b16-14+/t21-,24?/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| 32 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP4 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50142479
(7-{(R)-2-[(E)-3-Hydroxy-3-(3-trifluoromethyl-pheny...)Show SMILES OC(\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O)c1cccc(c1)C(F)(F)F Show InChI InChI=1S/C21H26F3NO4/c22-21(23,24)16-7-5-6-15(14-16)18(26)11-9-17-10-12-19(27)25(17)13-4-2-1-3-8-20(28)29/h5-7,9,11,14,17-18,26H,1-4,8,10,12-13H2,(H,28,29)/b11-9+/t17-,18?/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 140 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP4 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50142478
(7-[(R)-2-((E)-3-Biphenyl-3-yl-3-hydroxy-propenyl)-...)Show SMILES OC(\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O)c1cccc(c1)-c1ccccc1 Show InChI InChI=1S/C26H31NO4/c28-24(22-12-8-11-21(19-22)20-9-4-3-5-10-20)16-14-23-15-17-25(29)27(23)18-7-2-1-6-13-26(30)31/h3-5,8-12,14,16,19,23-24,28H,1-2,6-7,13,15,17-18H2,(H,30,31)/b16-14+/t23-,24?/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 360 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP4 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50142487
(7-{(R)-2-[(E)-3-(4'-Chloro-biphenyl-3-yl)-3-hydrox...)Show SMILES OC(\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O)c1cccc(c1)-c1ccc(Cl)cc1 Show InChI InChI=1S/C26H30ClNO4/c27-22-11-9-19(10-12-22)20-6-5-7-21(18-20)24(29)15-13-23-14-16-25(30)28(23)17-4-2-1-3-8-26(31)32/h5-7,9-13,15,18,23-24,29H,1-4,8,14,16-17H2,(H,31,32)/b15-13+/t23-,24?/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 390 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Agonist activity against recombinant prostanoid EP4 receptor stably transfected in CHO cells |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50142475
(7-{(R)-2-[(E)-3-(3'-Chloro-biphenyl-3-yl)-3-hydrox...)Show SMILES OC(\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O)c1cccc(c1)-c1cccc(Cl)c1 Show InChI InChI=1S/C26H30ClNO4/c27-22-10-6-8-20(18-22)19-7-5-9-21(17-19)24(29)14-12-23-13-15-25(30)28(23)16-4-2-1-3-11-26(31)32/h5-10,12,14,17-18,23-24,29H,1-4,11,13,15-16H2,(H,31,32)/b14-12+/t23-,24?/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 420 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP4 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50142485
(7-[(R)-2-((E)-3-Hydroxy-3-phenyl-propenyl)-5-oxo-p...)Show SMILES OC(\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O)c1ccccc1 Show InChI InChI=1S/C20H27NO4/c22-18(16-8-4-3-5-9-16)13-11-17-12-14-19(23)21(17)15-7-2-1-6-10-20(24)25/h3-5,8-9,11,13,17-18,22H,1-2,6-7,10,12,14-15H2,(H,24,25)/b13-11+/t17-,18?/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 2.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP4 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP3 subtype
(Homo sapiens (Human)) | BDBM50142481
(7-[(R)-2-((E)-(S)-3-Hydroxy-oct-1-enyl)-5-oxo-pyrr...)Show SMILES CCCCC[C@H](O)\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O Show InChI InChI=1S/C19H33NO4/c1-2-3-6-9-17(21)13-11-16-12-14-18(22)20(16)15-8-5-4-7-10-19(23)24/h11,13,16-17,21H,2-10,12,14-15H2,1H3,(H,23,24)/b13-11+/t16-,17-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 3.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP3 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50142487
(7-{(R)-2-[(E)-3-(4'-Chloro-biphenyl-3-yl)-3-hydrox...)Show SMILES OC(\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O)c1cccc(c1)-c1ccc(Cl)cc1 Show InChI InChI=1S/C26H30ClNO4/c27-22-11-9-19(10-12-22)20-6-5-7-21(18-20)24(29)15-13-23-14-16-25(30)28(23)17-4-2-1-3-8-26(31)32/h5-7,9-13,15,18,23-24,29H,1-4,8,14,16-17H2,(H,31,32)/b15-13+/t23-,24?/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 4.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP2 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50142481
(7-[(R)-2-((E)-(S)-3-Hydroxy-oct-1-enyl)-5-oxo-pyrr...)Show SMILES CCCCC[C@H](O)\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O Show InChI InChI=1S/C19H33NO4/c1-2-3-6-9-17(21)13-11-16-12-14-18(22)20(16)15-8-5-4-7-10-19(23)24/h11,13,16-17,21H,2-10,12,14-15H2,1H3,(H,23,24)/b13-11+/t16-,17-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 4.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP2 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP3 subtype
(Homo sapiens (Human)) | BDBM50142490
(7-{(R)-2-[(E)-3-Hydroxy-3-(5-trifluoromethyl-furan...)Show SMILES OC(\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O)c1ccc(o1)C(F)(F)F Show InChI InChI=1S/C19H24F3NO5/c20-19(21,22)16-10-9-15(28-16)14(24)8-6-13-7-11-17(25)23(13)12-4-2-1-3-5-18(26)27/h6,8-10,13-14,24H,1-5,7,11-12H2,(H,26,27)/b8-6+/t13-,14?/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| 4.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP3 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP3 subtype
(Homo sapiens (Human)) | BDBM50142489
(7-{(S)-2-[(R)-3-Hydroxy-3-(3-trifluoromethyl-pheny...)Show SMILES O[C@H](CC[C@H]1CCC(=O)N1CCCCCCC(O)=O)c1cccc(c1)C(F)(F)F Show InChI InChI=1S/C21H28F3NO4/c22-21(23,24)16-7-5-6-15(14-16)18(26)11-9-17-10-12-19(27)25(17)13-4-2-1-3-8-20(28)29/h5-7,14,17-18,26H,1-4,8-13H2,(H,28,29)/t17-,18+/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 1.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP3 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP3 subtype
(Homo sapiens (Human)) | BDBM50142491
(7-{(R)-2-[(E)-3-Hydroxy-4-(3-trifluoromethyl-pheny...)Show SMILES OC(Cc1cccc(c1)C(F)(F)F)\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O Show InChI InChI=1S/C22H28F3NO4/c23-22(24,25)17-7-5-6-16(14-17)15-19(27)11-9-18-10-12-20(28)26(18)13-4-2-1-3-8-21(29)30/h5-7,9,11,14,18-19,27H,1-4,8,10,12-13,15H2,(H,29,30)/b11-9+/t18-,19?/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 1.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP3 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP3 subtype
(Homo sapiens (Human)) | BDBM50142482
(7-{(R)-2-[(E)-(S)-3-Hydroxy-4-(3-trifluoromethyl-p...)Show SMILES O[C@@H](Cc1cccc(c1)C(F)(F)F)\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O Show InChI InChI=1S/C22H28F3NO4/c23-22(24,25)17-7-5-6-16(14-17)15-19(27)11-9-18-10-12-20(28)26(18)13-4-2-1-3-8-21(29)30/h5-7,9,11,14,18-19,27H,1-4,8,10,12-13,15H2,(H,29,30)/b11-9+/t18-,19+/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 1.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP3 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP3 subtype
(Homo sapiens (Human)) | BDBM50142477
(7-[(R)-2-((E)-(S)-4-Cyclohexyl-3-hydroxy-but-1-eny...)Show SMILES O[C@@H](CC1CCCCC1)\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O Show InChI InChI=1S/C21H35NO4/c23-19(16-17-8-4-3-5-9-17)13-11-18-12-14-20(24)22(18)15-7-2-1-6-10-21(25)26/h11,13,17-19,23H,1-10,12,14-16H2,(H,25,26)/b13-11+/t18-,19+/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 1.60E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP3 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP3 subtype
(Homo sapiens (Human)) | BDBM50125409
(7-{(R)-2-[(E)-3-Hydroxy-3-(1-phenyl-cyclopropyl)-p...)Show SMILES OC(\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O)C1(CC1)c1ccccc1 Show InChI InChI=1S/C23H31NO4/c25-20(23(15-16-23)18-8-4-3-5-9-18)13-11-19-12-14-21(26)24(19)17-7-2-1-6-10-22(27)28/h3-5,8-9,11,13,19-20,25H,1-2,6-7,10,12,14-17H2,(H,27,28)/b13-11+/t19-,20?/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP3 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50142488
(7-((S)-2-((R)-3-hydroxy-4-(3-(trifluoromethyl)phen...)Show SMILES O[C@H](CC[C@H]1CCC(=O)N1CCCCCCC(O)=O)Cc1cccc(c1)C(F)(F)F Show InChI InChI=1S/C22H30F3NO4/c23-22(24,25)17-7-5-6-16(14-17)15-19(27)11-9-18-10-12-20(28)26(18)13-4-2-1-3-8-21(29)30/h5-7,14,18-19,27H,1-4,8-13,15H2,(H,29,30)/t18-,19+/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 2.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP2 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50142484
(7-{(S)-2-[(R)-3-Hydroxy-3-(4'-hydroxy-2'-methyl-bi...)Show SMILES Cc1cc(O)ccc1-c1cccc(c1)[C@H](O)CC[C@H]1CCC(=O)N1CCCCCCC(O)=O Show InChI InChI=1S/C27H35NO5/c1-19-17-23(29)12-13-24(19)20-7-6-8-21(18-20)25(30)14-10-22-11-15-26(31)28(22)16-5-3-2-4-9-27(32)33/h6-8,12-13,17-18,22,25,29-30H,2-5,9-11,14-16H2,1H3,(H,32,33)/t22-,25+/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 2.60E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP2 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP1 subtype
(Homo sapiens (Human)) | BDBM50125409
(7-{(R)-2-[(E)-3-Hydroxy-3-(1-phenyl-cyclopropyl)-p...)Show SMILES OC(\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O)C1(CC1)c1ccccc1 Show InChI InChI=1S/C23H31NO4/c25-20(23(15-16-23)18-8-4-3-5-9-18)13-11-19-12-14-21(26)24(19)17-7-2-1-6-10-22(27)28/h3-5,8-9,11,13,19-20,25H,1-2,6-7,10,12,14-17H2,(H,27,28)/b13-11+/t19-,20?/m0/s1 | KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 2.80E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP1 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50142482
(7-{(R)-2-[(E)-(S)-3-Hydroxy-4-(3-trifluoromethyl-p...)Show SMILES O[C@@H](Cc1cccc(c1)C(F)(F)F)\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O Show InChI InChI=1S/C22H28F3NO4/c23-22(24,25)17-7-5-6-16(14-17)15-19(27)11-9-18-10-12-20(28)26(18)13-4-2-1-3-8-21(29)30/h5-7,9,11,14,18-19,27H,1-4,8,10,12-13,15H2,(H,29,30)/b11-9+/t18-,19+/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 2.90E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP2 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50125417
(7-[(R)-2-((E)-3-Hydroxy-4-phenyl-but-1-enyl)-5-oxo...)Show SMILES OC(Cc1ccccc1)\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O Show InChI InChI=1S/C21H29NO4/c23-19(16-17-8-4-3-5-9-17)13-11-18-12-14-20(24)22(18)15-7-2-1-6-10-21(25)26/h3-5,8-9,11,13,18-19,23H,1-2,6-7,10,12,14-16H2,(H,25,26)/b13-11+/t18-,19?/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 3.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP2 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50142478
(7-[(R)-2-((E)-3-Biphenyl-3-yl-3-hydroxy-propenyl)-...)Show SMILES OC(\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O)c1cccc(c1)-c1ccccc1 Show InChI InChI=1S/C26H31NO4/c28-24(22-12-8-11-21(19-22)20-9-4-3-5-10-20)16-14-23-15-17-25(29)27(23)18-7-2-1-6-13-26(30)31/h3-5,8-12,14,16,19,23-24,28H,1-2,6-7,13,15,17-18H2,(H,30,31)/b16-14+/t23-,24?/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 3.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP2 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP3 subtype
(Homo sapiens (Human)) | BDBM50142488
(7-((S)-2-((R)-3-hydroxy-4-(3-(trifluoromethyl)phen...)Show SMILES O[C@H](CC[C@H]1CCC(=O)N1CCCCCCC(O)=O)Cc1cccc(c1)C(F)(F)F Show InChI InChI=1S/C22H30F3NO4/c23-22(24,25)17-7-5-6-16(14-17)15-19(27)11-9-18-10-12-20(28)26(18)13-4-2-1-3-8-21(29)30/h5-7,14,18-19,27H,1-4,8-13,15H2,(H,29,30)/t18-,19+/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 3.80E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP3 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP3 subtype
(Homo sapiens (Human)) | BDBM50142476
(7-{(R)-2-[(E)-3-(4'-Chloro-2'-methyl-biphenyl-3-yl...)Show SMILES Cc1cc(Cl)ccc1-c1cccc(c1)C(O)\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O Show InChI InChI=1S/C27H32ClNO4/c1-19-17-22(28)10-13-24(19)20-7-6-8-21(18-20)25(30)14-11-23-12-15-26(31)29(23)16-5-3-2-4-9-27(32)33/h6-8,10-11,13-14,17-18,23,25,30H,2-5,9,12,15-16H2,1H3,(H,32,33)/b14-11+/t23-,25?/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid UniChem
Similars
| Article PubMed
| 3.80E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP3 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50142485
(7-[(R)-2-((E)-3-Hydroxy-3-phenyl-propenyl)-5-oxo-p...)Show SMILES OC(\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O)c1ccccc1 Show InChI InChI=1S/C20H27NO4/c22-18(16-8-4-3-5-9-16)13-11-17-12-14-19(23)21(17)15-7-2-1-6-10-20(24)25/h3-5,8-9,11,13,17-18,22H,1-2,6-7,10,12,14-15H2,(H,24,25)/b13-11+/t17-,18?/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 4.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP2 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50142493
(7-{(R)-2-[(E)-3-(2'-Chloro-biphenyl-3-yl)-3-hydrox...)Show SMILES OC(\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O)c1cccc(c1)-c1ccccc1Cl Show InChI InChI=1S/C26H30ClNO4/c27-23-11-5-4-10-22(23)19-8-7-9-20(18-19)24(29)15-13-21-14-16-25(30)28(21)17-6-2-1-3-12-26(31)32/h4-5,7-11,13,15,18,21,24,29H,1-3,6,12,14,16-17H2,(H,31,32)/b15-13+/t21-,24?/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 4.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP2 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP1 subtype
(Homo sapiens (Human)) | BDBM50142486
(7-{(R)-2-[(E)-3-Hydroxy-3-(3-phenoxy-phenyl)-prope...)Show SMILES OC(\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O)c1cccc(Oc2ccccc2)c1 Show InChI InChI=1S/C26H31NO5/c28-24(20-9-8-12-23(19-20)32-22-10-4-3-5-11-22)16-14-21-15-17-25(29)27(21)18-7-2-1-6-13-26(30)31/h3-5,8-12,14,16,19,21,24,28H,1-2,6-7,13,15,17-18H2,(H,30,31)/b16-14+/t21-,24?/m0/s1 | KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| 5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP1 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP3 subtype
(Homo sapiens (Human)) | BDBM50142474
(7-[(R)-2-((E)-(S)-4-Cyclobutyl-3-hydroxy-but-1-eny...)Show SMILES O[C@@H](CC1CCC1)\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O Show InChI InChI=1S/C19H31NO4/c21-17(14-15-6-5-7-15)11-9-16-10-12-18(22)20(16)13-4-2-1-3-8-19(23)24/h9,11,15-17,21H,1-8,10,12-14H2,(H,23,24)/b11-9+/t16-,17+/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 5.60E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP3 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50142490
(7-{(R)-2-[(E)-3-Hydroxy-3-(5-trifluoromethyl-furan...)Show SMILES OC(\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O)c1ccc(o1)C(F)(F)F Show InChI InChI=1S/C19H24F3NO5/c20-19(21,22)16-10-9-15(28-16)14(24)8-6-13-7-11-17(25)23(13)12-4-2-1-3-5-18(26)27/h6,8-10,13-14,24H,1-5,7,11-12H2,(H,26,27)/b8-6+/t13-,14?/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| 5.80E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP2 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50142479
(7-{(R)-2-[(E)-3-Hydroxy-3-(3-trifluoromethyl-pheny...)Show SMILES OC(\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O)c1cccc(c1)C(F)(F)F Show InChI InChI=1S/C21H26F3NO4/c22-21(23,24)16-7-5-6-15(14-16)18(26)11-9-17-10-12-19(27)25(17)13-4-2-1-3-8-20(28)29/h5-7,9,11,14,17-18,26H,1-4,8,10,12-13H2,(H,28,29)/b11-9+/t17-,18?/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 6.80E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP2 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50142477
(7-[(R)-2-((E)-(S)-4-Cyclohexyl-3-hydroxy-but-1-eny...)Show SMILES O[C@@H](CC1CCCCC1)\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O Show InChI InChI=1S/C21H35NO4/c23-19(16-17-8-4-3-5-9-17)13-11-18-12-14-20(24)22(18)15-7-2-1-6-10-21(25)26/h11,13,17-19,23H,1-10,12,14-16H2,(H,25,26)/b13-11+/t18-,19+/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 7.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP2 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50142475
(7-{(R)-2-[(E)-3-(3'-Chloro-biphenyl-3-yl)-3-hydrox...)Show SMILES OC(\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O)c1cccc(c1)-c1cccc(Cl)c1 Show InChI InChI=1S/C26H30ClNO4/c27-22-10-6-8-20(18-22)19-7-5-9-21(17-19)24(29)14-12-23-13-15-25(30)28(23)16-4-2-1-3-11-26(31)32/h5-10,12,14,17-18,23-24,29H,1-4,11,13,15-16H2,(H,31,32)/b14-12+/t23-,24?/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 8.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP2 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP3 subtype
(Homo sapiens (Human)) | BDBM50142475
(7-{(R)-2-[(E)-3-(3'-Chloro-biphenyl-3-yl)-3-hydrox...)Show SMILES OC(\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O)c1cccc(c1)-c1cccc(Cl)c1 Show InChI InChI=1S/C26H30ClNO4/c27-22-10-6-8-20(18-22)19-7-5-9-21(17-19)24(29)14-12-23-13-15-25(30)28(23)16-4-2-1-3-11-26(31)32/h5-10,12,14,17-18,23-24,29H,1-4,11,13,15-16H2,(H,31,32)/b14-12+/t23-,24?/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP3 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP2 subtype
(Homo sapiens (Human)) | BDBM50142476
(7-{(R)-2-[(E)-3-(4'-Chloro-2'-methyl-biphenyl-3-yl...)Show SMILES Cc1cc(Cl)ccc1-c1cccc(c1)C(O)\C=C\[C@H]1CCC(=O)N1CCCCCCC(O)=O Show InChI InChI=1S/C27H32ClNO4/c1-19-17-22(28)10-13-24(19)20-7-6-8-21(18-20)25(30)14-11-23-12-15-26(31)29(23)16-5-3-2-4-9-27(32)33/h6-8,10-11,13-14,17-18,23,25,30H,2-5,9,12,15-16H2,1H3,(H,32,33)/b14-11+/t23-,25?/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid UniChem
Similars
| Article PubMed
| >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Roche Palo Alto
Curated by ChEMBL
| Assay Description Binding affinity was determined against prostanoid EP2 receptor |
Bioorg Med Chem Lett 14: 1655-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.01.063 BindingDB Entry DOI: 10.7270/Q2MK6CBC |
More data for this Ligand-Target Pair | |